Nicolas De Leiris (Nicolas de Leiris)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Journal of translational medicine

Cancer imaging : the official publication of the International Cancer Imaging Society

Diagnostics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolas De Leiris, Pascale Perret, Charlotte Lombardi, Bülent Gözel, Sabine Chierici, Philippe Millet, Marlène Debiossat, Sandrine Bacot, Benjamin B Tournier, Patrick Chames, Jean-Luc Lenormand, Catherine Ghezzi, Daniel Fagret, Marcelle Moulin
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. Journal of translational medicine 22 (1) (2024)
Nicolas De Leiris, Pascale Perret, Charlotte Lombardi, Bülent Gözel, Sabine Chierici, Philippe Millet, Marlène Debiossat, Sandrine Bacot, Benjamin B Tournier, Patrick Chames, Jean-Luc Lenormand, Catherine Ghezzi, Daniel Fagret, Marcelle Moulin
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. Journal of translational medicine 22 (1) (2024)
Nicolas De Leiris, Pascale Perret, Charlotte Lombardi, Bülent Gözel, Sabine Chierici, Philippe Millet, Marlène Debiossat, Sandrine Bacot, Benjamin B Tournier, Patrick Chames, Jean-Luc Lenormand, Catherine Ghezzi, Daniel Fagret, Marcelle Moulin
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. Journal of translational medicine 22 (1) (2024)
Nicolas De Leiris, Pascale Perret, Charlotte Lombardi, Bülent Gözel, Sabine Chierici, Philippe Millet, Marlène Debiossat, Sandrine Bacot, Benjamin B Tournier, Patrick Chames, Jean-Luc Lenormand, Catherine Ghezzi, Daniel Fagret, Marcelle Moulin
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. Journal of translational medicine 22 (1) (2024)
Anthime Flaus, Vincent Habouzit, Nicolas De Leiris, Jean-Philippe Vuillez, Marie-Thérèse Leccia, Mathilde Simonson, Jean Luc Perrot, Florent Cachin, Nathalie Prévôt
Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment. Diagnostics (Basel, Switzerland) 12 (2) (2022)
Pauline Orhon, Marie-Dominique Desruet, Marie Piquemal, Nicolas De Leiris, Loïc Djaileb, Jean-Philippe Vuillez, Pierrick Bedouch, Leenhardt Julien
Development and Validation of Analytical Methods for Radiochemical Purity of 177 Lu-PSMA-1. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, Jérôme Durivault, Marc Faraggi, Gilles Pagès
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine? International journal of molecular sciences 22 (12) (2021)
Nicolas De Leiris, Julien Leenhardt, Bastien Boussat, Christopher Montemagno, Alexandre Seiller, Olivier Phan Sy, Julie Roux, Mathieu Laramas, Camille Verry, Carole Iriart, Gaelle Fiard, Jean-Alexandre Long, Jean-Luc Descotes, Jean-Philippe Vuillez, Laurent Riou, Loïc Djaileb
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence? Cancer imaging : the official publication of the International Cancer Imaging Society 20 (1) (2020)

Nicolas De Leiris.css-eqlu8i{font-size:small;padding-left:4px;} (Nicolas de Leiris)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas De Leiris (Nicolas de Leiris)